Search

Your search keyword '"Eriksson, A. I."' showing total 56 results

Search Constraints

Start Over You searched for: Author "Eriksson, A. I." Remove constraint Author: "Eriksson, A. I." Publisher elsevier bv Remove constraint Publisher: elsevier bv
56 results on '"Eriksson, A. I."'

Search Results

2. Association between cerebrospinal fluid biomarkers of neuronal injury or amyloidosis and cognitive decline after major surgery

3. Improving perioperative brain health: an expert consensus review of key actions for the perioperative care team

5. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

6. Corrigendum to ‘State of the clinical science of perioperative brain health: report from the American Society of Anesthesiologists Brain Health Initiative Summit 2018’ (Br J Anaesth 2019; 123: 464–478)

7. State of the clinical science of perioperative brain health: report from the American Society of Anesthesiologists Brain Health Initiative Summit 2018

9. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study

12. An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150 mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery

23. Perioperative Cognitive Decline in the Aging Population

25. POOLED ANALYSIS OF FOUR STUDIES OF RIVAROXABAN: EFFECT ON SYMPTOMATIC EVENTS AND BLEEDING AND THE INFLUENCE OF CLINICALLY RELEVANT PATIENT SUBGROUPS

27. Levosimendan Facilitates Weaning From Cardiopulmonary Bypass in Patients Undergoing Coronary Artery Bypass Grafting With Impaired Left Ventricular Function

29. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

32. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial

33. Dose-escalation study of rivaroxaban (BAY 59-7939) – an oral, direct Factor Xa inhibitor – for the prevention of venous thromboembolism in patients undergoing total hip replacement

49. Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement

Catalog

Books, media, physical & digital resources